Northern Trust
CMLTU

Northern Trust’s CM Life Sciences III Inc. Unit CMLTU Stock Holding History

Northern Trust’s Portfolio CMLTU Stock Details CMLTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,618
Closed -$127K – 4781
2021
Q2 		$127K Buy
+11,618
New +$125K ﹤0.01% 4302

Other funds holding CMLTU

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Northern Trust's CMLTU Position: Q3 2021 in Review

Northern Trust sold out of CM Life Sciences III Inc. Unit (CMLTU) in Q3 2021, closing a stake of 11,618 shares — an estimated $127K sold.

Northern Trust first reported a position in CMLTU in Q2 2021 and held it in 1 quarter. The position peaked at $127K in Q2 2021. 28 funds tracked by Wall St. Rank hold CMLTU as of Q3 2021.

  • Northern Trust reported no remaining CM Life Sciences III Inc. Unit position as of Q3 2021 after selling out during the quarter.
  • Northern Trust sold 11,618 CM Life Sciences III Inc. Unit shares in Q3 2021, an estimated $127K.
  • Northern Trust first reported a position in CM Life Sciences III Inc. Unit in Q2 2021 and held it in 1 quarter.
  • Northern Trust's CM Life Sciences III Inc. Unit position peaked at $127K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held CM Life Sciences III Inc. Unit as of Q3 2021.

Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.